Traditional Clinicopathological Biomarkers Still Determine Disease-Free and Overall Survival in Invasive Breast Cancer Patients: A Pilot Study

Conclusions: Our study provides essential information on the clinicopathological profile and future outcomes of early stage IBrC patients. Furthermore, the tumor diameter cut-off value of 1.6 cm discriminating between disease recurrence and those without disease progression patients represents an innovative direction for further research.PMID:38610786 | DOI:10.3390/jcm13072021

Source: Clinical Breast Cancer - April 13, 2024 Category: Cancer & Oncology Authors: Katarzyna Wrzeszcz Katarzyna Kwiatkowska Piotr Rhone Dorota Formanowicz Stefan Kruszewski Barbara Ruszkowska-Ciastek Source Type: research